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1. Introduction 
This study will present contemporary methods of the knee osteoarthrosis (OA) diagnosis – 
arthrosonography and biomarkers, which are applied and recommended in the modern 
practice.  
Advantages of ultrasound diagnostics (arthrosonography) and serum biomarkers in 
rheumatologic diagnostics will be documented through this research which applied these 
methods. Ultrasound has become an integral part of clinical practice and is applied in many 
fields of medicine, however, in rheumatology it has not been fully recognized yet. Appliance 
of biomarkers in knee osteoarthrosis diagnosis is considerably a more expensive method, 
and has not been usually used for this purpose. It is very precise though in detection of 
changes in knee joint with osteoarthrosis.  
The goal of this study is to affirm the ultrasound diagnostic method for many advantages it 
has comparing to other methods which have been used as routine, and to recommend it as a 
important part of clinical rheumatologic checkup.  
The following methods are usually used for visualisation of knee joint: radiography, nuclear 
magnet resonance, computerised tomography, arthroscopy and arthrography. The most 
commonly applied and routine diagnostic method is radiography. However, the 
conventional radiography and computerised tomography are the methods without 
possibility of direct visualisation of the joint cartilage. Narrowing of the joint area is only an 
indirect indication of a joint damage, and early changes on the cartilage cannot be evaluated 
(Batalov et al.,2000). Nuclear magnetic resonance provides direct information on changes in 
different joint tissues, which is why it is nowadays appropriate for the knee osteoarthrosis 
diagnosis. However, its appliance is limited due to the very expensive medical examination. 
Methods of direct visualisation of the joint cartilage are arthrography and arthroscopy, 
which are less used in clinical practice, due to their invasiveness and limited indications.  
2. Contemporary diagnostics of the knee osteoarthrosis  
Ultrasound examination is non-invasive and much more accessible for evaluation of a large 
number of patients than other imaging modalities. The European League Against 
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Rheumatism in the first and second part of the Report from 2005 (D'Agostino et al., 2005, 
Conaghan et al 2005) recommends ultrasound medical technique as a golden standard in 
diagnosis of pathological changes in the knee joint, and also recommends arthrosonographic 
measuring and techniques.  
This study will present results of the prospective research, which comprises 88 patients with 
diagnosis of primary knee osteoarthrosis, according to criteria of the American College of 
Rheumatology – ACR. Information about pain intensity in the knee was obtained from the 
patients through anamnesis during the last two weeks, measuring the frequency and 
intensity of pain during the night, as well as stiffness after a period of rest. Pain intensity 
was numerically evaluated marking the pain spots on VAS from 0 – 100 mm. Clinical 
examination of the both knees determined presence or absence of abnormal knee fluid 
buildup (arthritis) which was evaluated as serious, moderate, minimal or absent, as well as 
presence or absence of the Baker's cyst. The knee function was evaluated according to the 
scope of flexion in degrees. Based on HAQ index, the overall health condition of patients 
was assessed, and the functional ability marked as moderate or serious inability and the 
need for nursing and assistance. An ultrasound examination of the both knees in the B mode 
was done by a two rheumatologist on SDU – 1200 device, using a linear probe of 10MHz. 
Frontal longitudinal view was used to determined presence or absence of synovial 
inflammation indicators: effusion – defined as the scope of fluid buildup larger than 4mm in 
the knee suprapatellar, medial or lateral recess (SR, MR, LR); synovitis – defined as 
thickening of synovial membrane over 4mm.  
The maximal depth of effusion and thickness of synovial tissue were measured and 
presented in mm. Morphologically, effusion was marked as absent or present in 
suprapatellar, medial or lateral knee recess, while synovitis was marked as absent or 
present (in nodular, difusal or nodular-difusal mode). Arthrosonography determined 
existence and size of the Baker's cyst behind the knee joint, as well as existence and 
thickness of synovitis inside it. Measurement of cartilage thickness was conducted in 
transversal view at medial and lateral femur condyle, at 90 degree knee bend, and 
posterior longitudinal view at medial femur condyle when the knee was extended (in 
mm). The existence and size of osteophytes (denoted as shorter or ≤2mm, and longer or ≥ 
2mm) and bone erosions were established by lateral view on femur and tibia medial and 
lateral condyles. Analysis of serum samples determined concentration of COMP (ng/ml), 
YKL – 40 (ng/ml) and CTX-I (ng/ml) by ELISA (Enzyme-Linked ImmunoSorbent Assay) 
methods, using Cartilage Oligo Metric Protein kit (Euro-diagnostica Wieslab tm hCOMP 
quantitative kit), YKL-40 for Rheumatology and Oncology kit (Quidel, Metra- YKL-40 
EIA kit) and Serum Crosslaps (Nordic Bioscience Diagnostica). The research excluded 
the patients who had the knee damage six months before the research, the patients with 
the total or partial endoprosthesis or the knee joint osteotomy, with arthroscopy of the 
knee joint in the past year, and the patients who had been treated with intraarticularly 
injected corticosteroids or hondroprotective four weeks before enrollment into the 
research.  
Due to appliance of YKL-40 biomarkers, it was also necessary to exclude the patients with 
rheumatoid arthritis, inflammatory intestinal diseases, bacterial infections, liver fibrosis and 
malignant diseases. Presentation of these results will be compared with the results of other 
researches in this field. The advantages of ultrasound diagnostic methods and biomarkers 
will be documented as contemporary knee osteoarthrosis diagnostic methods in clinical 
practice.  
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The mean age of patients was 69,97±9,37 (44 – 88) years. Women prevailed and had even 3,4 
times more frequent osteoarthrosis than men, which complies with the data available in 
literature, according to which osteoarthrosis is more frequent in female subjects (Hart et al., 
1999). Duration of the knee osteoarthrosis in the patients enrolled this  study was 6,46±6,73 
(0,5-37), which indicates initiation of osteoarthrosis in certain patients between 40 and 50 
years of age. Epidemiological researches have shown that in the developed countries 50% of 
population older than 40 can prove arthritic joint changes, but are mainly without 
symptoms at this age. 
2.1 Clinical evaluation of the knee osteoarthrosis deterioration parameters 
Knee osteoarthrosis deterioration evaluation is usually done by clinical estimation of the 
pain intensity according to Dougados (Dougados et al,.1997), which implies estimation of 
the pain intensity in the knee, estimation of the pain occurring during the night, and 
presence of fluid buildup (effusion) in knee joint. According to Dougados, estimation of the 
pain intensity in the knee is done by indication on the part of the patients experiencing the 
pain, using the pain VAS (0-100 mm) and by clinical estimation of knee osteoarthrosis 
degree on the part of medical doctors according to VAS for overall estimation of the disease 
degree (0-100 mm). Mean value of the pain intensity on VAS was 58,86±22,56. The medical 
doctor's evaluation of the clinical degree of osteoarthrosis on VAS (mm) was 40,45±18,31 
average.  
Among the subjects, only the patients with deterioration and evaluation on VAS over 30 mm 
expirienced stiffness longer than 30 min. as well as the night pain. Clinical examination 
determined knee fluid buildup in 54 (61,3%) of the patients. Fifteen patients (17%) had the 
Baker's cyst. Based on the clinical evaluation of knee osteoarthrosis deterioration according 
to Dougados, all the patients were divided in two groups: 74 patients with knee 
osteoarthrosis deterioration and pain mark over 30 mm on VAS, and 14 patients without 
deterioration and pain mark below 30 mm on VAS.  
Comparing the groups of patients with and without knee osteoarthrosis deterioration, with 
reference to the years of age (p=0,118) and duration of disease (p=0,211) no significant 
difference was indicated. The mean age of patients and duration of disease were similar in 
the both groups of surveyed patients.  
Increased body weight, verified by the higher BMI is associated with incidence and 
progression of knee osteoarthrosis, according to the results of the Rotterdam study 
(Reijman et al.,2007). Even 81,8% of knee osteoarthrosis patients had the body weight over 
the optimum. The patients with pain intensity mark over 30mm on the pain VAS had 
higher body weight – BMI 29,37±1,08 kg/m² than the patients with smaller knee pain 
intensity – BMI 25,04±2,46 kg/m² (p=0,000). In this way, it was confirmed that the 
excessive body weight is the risk factor which contributes to deterioration of knee 
osteoarthrosis. 
The knee fluid buildup is a clinical characteristic of osteoarthrosis, which most commonly 
occurs in progressive osteoarthrosis, but can also often occur at the initial phases of OA 
during the periods of disease deteriorating. In the group of patients with the deteriorated 
knee osteoarthrosis and the pain mark over 30mm on VAS, 29,7% of the patients were 
without abnormal fluid buildup, while in the group of patients without osteoarthrosis 
deterioration, there were significantly more patients without fluid buildup (85,71%). 
Minimal fluid buildup was present at 37,8% of the patients with the pain mark over 30 mm 
on VAS. The result of moderate fluid buildup was confirmed by a clinical examination of 
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27% of the patients, and of the serious fluid buildup in 5,4% of the patients, in the group of 
patients with osteoarthrosis deterioration. In the group of patients without osteoarthrosis 
deterioration neither moderate nor serious knee fluid buildups were detected. Baker's cyst 
was diagnosed by clinical examination in 18,1% of the patients with the pain mark over 30 
mm on VAS and 7,1% of the patients with lesser pain intensity (Figure 1.). It was concluded 
that the pain intensity marked on VAS by the patients considerably differed when minimal, 
moderate or serious knee fluid buildup was found by the clinical examination, or it was 
absent (p=0,014), which confirms that inflammation contributes to stronger pain in the knee 
joint (Živanović et al.,2009).  
 
 
Fig. 1. Comparison of the size of outpour (minimal, medium and important) between the 
patients with pain scores greater and lower than 30mm on VAS pain scale 
The fact was confirmed that small and large crepitations occur in deteriorated 
osteoarthrosis, with the presence of both stronger pain and synovial inflammation. The 
patients with deteriorated osteoarthrosis and stronger pain had significantly limited 
movements in the knee joint, comparing to patients without deterioration, as expected. A 
survey of the health condition confirmed higher degree of inability in the patients with 
deteriorated knee osteoarthrosis comparing to the patients without symptoms and 
indicators of deterioration, which complies with the data obtained from literature.The 
patients with more intensive pain and problems are more weighty, have limited knee 
movements and higher degree of inability, and vice versa.  
Longer duration of the disease causes more difficult clinical form of the disease, and the 
bigger body weight is associated with the doctors' estimation of a more difficult form of the 
disease. In the presence of a serious knee fluid buildup, doctor evaluates osteoarthrosis 
difficulty with the highest mark, as well as if reduced mobility is detected at a clinical 
examination and synovitis in suprapatellar recess detected on ultrasound.  
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2.1.1 Ultrasound diagnostics of inflammatory changes in the knee osteoarthrosis 
The average values of the size of effusion and synovitis in osteoarthrosis patients are highest 
in lateral recess, comparing to the values of same parameters in medial recess and 
suprapatellar recess. Based on the data that most of patients had effusion in lateral recess, 
and that clinically established moderate or minimal effusion is arthrosonographically shown 
as effusion only in lateral recess, it was concluded that inflammation most frequently occurs 
in this recess (Figure 2.).  
 
 
Fig. 2. Comparison of the middle value (median) size of effusion in suprapatellar, medial 
and/or lateral recess between patients with absent, minimal, medium and important 
outpour 
It was found that synovitis in suprapatellar recess causes serious effusion in all three knee 
recess and reflects intensive inflammation in the knee joint. Besides, synovitis in medial and 
lateral recess can cause effusion in the local recess, with suprapatellar extending (Figure 3.) 
(Živanović et al.,2009).  
Duration of disease does not influence appearance, size and locality of synovial 
inflammation, nor its deterioration in the patients with knee joint osteoarthrosis. 
Effusion at the clinical examination was present in 61,3% of the patients, while 
arthrosonographic examination found effusion in 75,0% of the patients. There is a significant 
difference between the frequencies of clinically found effusion (the knee fluid buildup) and 
presence of effusion found by arthrosonography, in the patients with knee osteoarthrosis 
(p=0,000). Six patients (11,1%) had clinical effusion, but not an ultrasound confirmed 
effusion. It is also important that in 52,9% of the patients effusion was not clinically found, 
but ultrasound determined its presence. Based on the facts presented above, it was 
established that sensitivity of clinical diagnosis of effusion is 73% (percentage of diagnosis of 
effusion by clinical examination in the group of patients who had effusion proved by 
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ultrasound), while specificity of clinical diagnosis of effusion is 73% (percentage of 
diagnosis of effusion by clinical checkup in the group of patients who had no effusion 
proved by ultrasound) (Table 1.)  (Živanović et al.,2009).  
 
 
Fig. 3. Comparison of the middle value (median) thicknees of synovitis in suprapatellar, 
medial and/or lateral recess between patients with absent, minimal, medium and important 
outpour 
 
clinical 
findings 
of 
effusion 
Ultrasound findings of effusion 
absent present total 
Number 
of patient 
% 
Number 
of patient 
% 
Number 
of patient 
% 
absent 16 47,05 18 52,94 34 100 
present 6 11,11 48 88,88 54 100 
total 22 25,0 66 75,0 88 100 
      p=0,000 
Table 1. The frequency of clinical findings of effusion, and ultrasound-term findings of 
effusion in patients with knee OA 
Kane et al. recommend arthrosonography as the golden standard, because it is more 
sensitive than clinical checkup of the joint diseases, and suspect the precision on acurateness 
of detecting standardised Disease Activity Scores (DAS) based only on a clinical checkup 
(Kane et al.,2003).  
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2.1.2 The ultrasound parameter of the knee osteoarthrosis deterioration –  
Joint effusion and synovial proliferation  
Hill's research showed that moderate and serious effusions and synovial proliferation in the 
joint cause pain in the patients with knee osteoarthrosis (Hill et al.,2001).  
The knee pain intensity differs comparing to presence or absence of effusion found by 
ultrasound, regardless its location. It was established that effusion and synovial 
inflammation contribute to increase of pain in patients with knee osteoarthrosis. 
The average values of effusion size and synovial membrane thickness in the knee recess 
were higher in group of patients with the signs of knee arthrosis deterioration and the pain 
mark above 30 mm on VAS (Figure 4.5.).  
The largest effusion and synovitis occurred in the lateral recess. It is important that 
ultrasound also detected effusion in over 63% of patients with osteoarthrosis deterioration, 
but without clear clinical signs of effusion. The facts presented above indicate that 
ultrasound is more sensitive method than clinical examination at detection of synovial 
inflammation, especially in the patients with intensive pain, and without clinical signs of 
effusion. 
In the analyzed group of patients with osteoarthrosis, most of the patients had synovial 
inflammation in lateral recess and intensity of pain in the knee was related to the size of 
effusion and synovitis present in lateral recess (Table 2.,3.).  
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. The presence or absence of effusion in patients with pain score greater than 30 mm on 
the VAS pain scale and  with less than 30 mm on VAS pain scale 
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Fig. 5. The presence or absence of synovitis in patients with pain score greater than 30 mm 
on the VAS pain scale and  with less than 30 mm on VAS pain scale 
 
VAS 
effusion in suprapatellar 
recess (mm) 
25-th per medijan 75-th per 
> 30 0 0 6,12 
 30 0 0 0 
 p=0,123 
 
VAS 
effusion in medial 
recess (mm) 
25-th per medijan 75-th per 
> 30 0 0 5,09 
 30 0 0 0 
 p=0,015 
 
VAS 
effusion in lateral 
recess (mm) 
25-th per medijan. 75-th per 
> 30 0 4,83 7,71 
 30 0 0 4,41 
 p=0,010 
Table 2. Comparation average value of a quantity of effusion in suprapatellar, medial and 
lateral recess between the patients with pain scores greater and lower than 30 mm on VAS 
pain scale 
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VAS 
synovitis in suprapatellar 
recess (mm) 
5-ti per 10-ti per 25-ti per medijan. 75-ti per 90-ti per 95-ti per 
> 30 0 0 0 0 2,30 4,54 5,45 
≤ 30 0 0 0 0 0 1,48 0 
       p=0,146 
 
VAS 
synovitis in medial 
recess (mm) 
5-ti per 10-ti per 25-ti per medijan. 75-ti per 90-ti per 95-ti per 
> 30 0 0 0 0 0 2,83 3,76 
≤ 30 0 0 0 0 0 0 0 
       p=0,049 
 
VAS 
synovitis in lateral 
recess (mm) 
5-ti per 10-ti per 25-ti per medijan. 75-ti per 90-ti per 95-ti per 
> 30 0 0 0 1,88 3,55 5,82 7,06 
≤ 30 0 0 0 0 2,52 3,06  
       p=0,054 
Table 3. Comparation average value of a quantity of synovitis in suprapatellar, medial and 
lateral recess between the patients with pain scores greater and lower than 30mm on VAS 
pain scale 
2.1.3 Ultrasound diagnostics of destructive changes in osteoarthrosis  
The ultrasound parameters of cartilage and bone destructions are the reduced thickness of 
cartilage and detected osteophytes and bone erosions.  
The cartilage and bone damages progress with the age and the duration of disease.  
In the knee osteoarthrosis, cartilage damages primarily and most excessively occur medially, 
i.e. degenerative changes are the most intensive in the medial condyle, which complies with 
the data from literature (Pilipović, 2000).  
2.1.4 Ultrasound diagnosis of the Baker's cyst 
The Baker's cyst is a frequent pathological finding in the knee popliteal area. This  research 
proved that the presence of a Baker's cyst found by a clinical examination depends on the 
presence and size of effusion. The most frequently, Baker's cyst is found clinically in patients 
who have serious effusion in the knee. Rarely can the Baker's cyst be palpated and found in 
the popliteal area and in the patients without effusion. Only 8,82% of patients without 
effusion had Baker's cyst at the clinical examination, while in over a fourth (26,5%) of the 
patients without clinical signs of effusion, Baker's cyst was found by ultrasound. Only 20% 
of patients with clinical diagnosis of the Baker's cyst did not have the cyst at ultrasound 
examination, while in the majority of patients (80%), it was confirmed by ultrasound. In a 
considerable number of patients (37%) without clinical signs of Baker's cyst, the cyst was 
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proved by ultrasound. This large discrepancy in the frequency of diagnosed Baker's cysts in 
the knees with osteoarthrosis favorises the arthrosonography as the more precise method in 
detection of soft tissue deviations in popliteal area.  
It was calculated that sensitivity of clinical diagnosis of Baker's cyst was 30,77% (percentage 
of the correct diagnosis of Baker's cyst by clinical examination in the group of patients who 
indeed had the Baker's cyst proved by ultrasound). Specificity of the clinical diagnosis of 
Baker's cyst was 93,88% (percentage of diagnosis of Baker's cyst by clinical examination of 
the group of patients without an ultrasound proven Baker's cyst) (table 4).  
 
Baker cyst  
clinical 
diagnosis 
Baker cyst - ultrasound diagnosis 
absent present total 
Number 
of patient 
% 
Number 
of patient 
% 
Number 
of patient 
% 
absent 46 63,01 27 36,98 73 100 
present 3 20,0 12 80,0 15 100 
total 49 55,68 39 44,31 88 100 
      p=0,003 
Table 4. The relationship of clinical diagnosis of Baker cyst and arthrosonography diagnosis 
in patients with knee osteoarhrosis 
It was shown that the diagnosis of Baker's cyst at clinical examination mostly depends on its 
area (size) which can be measured by ultrasound (p=0,000), and does not depend on any 
other clinical nor ultrasound parameters. 
It was established that occurrence and size of the Baker's cyst depend on the size of effusion 
and synovitis in SR and LR. 
It was not determined that there is a significant difference in the presence or absence of the 
Baker's cyst at clinical examination between groups of patients with the pain mark over 30 
mm and below 30 mm on VAS (p=0,259). In contrast, it was proved that there is a significant 
correlation between the evaluation by the patients with knee OA on VAS and the Baker's 
cyst area measured by ultrasound (r=0,238, p=0,025), which means that the presence of a 
larger Baker's cyst in popliteal knee area contributes to stronger pain. These results are in 
complience with the Hill's research in 2001, which determined that the presence of Baker's 
cyst is associated with occurrence of pain (Hill et al.,2001). 
2.2 Predisposing factors of the knee osteoarthrosis deterioration  
The main risk factor for knee osteoarthrosis deterioration, apart from overweight and obesity, is 
occurrence of synovial inflammation, the intensity of which can be measured by 
arthrosonography, measuring the scope of effusion and synovitis thickness in recessses, 
especially the lateral recess, as well as by presence and size of Baker's cyst of the bad knee joint.  
It was not established that the joint destructions (occurrence of osteophyte and bone erosion 
on tibia and femur condyle) significantly influence the pain intensity increase, unlike 
synovial inflammation, effusion and synovitis.  
2.3 Biomarkers 
Biomarkers (biochemical markers) are molecules or fragments of connective tissue matrix 
which disperse into biological fluids during tissue metabolism. Their concentration can be 
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measured by immunoassay methods (Garnero et al.,2006). Measuring the concentration of 
these biomarkers may be complementary with imaging techniques following up the 
development of diseases such as rheumatoid arthritis and osteoarthrosis (Garnero et 
al.,2000). It is recommended to measure and simultaneously follow up concentrations of 
several markers on cartilage, bones and synovial metabolisms, because joining these 
markers can reflect metabolic changes in all three tissues, showing a better picture of 
pathophysiological changes in osteoarthrosis (Charni et al.,2005, Garnero et al.,2001). In this 
research three biomarkers were used: Cartilage Oligomeric Matrix Protein – COMP, human 
cartilage glycoprotein (YKL-40) known as the Human Cartilage Glycoprotein 39 (HC gp-39 
or GP-39) and Collagen type I C – terminal telopeptide (CTX-I). 
Cartilage Oligomeric Matrix Protein – COMP is a non-collagen protein of articular cartilage 
matrix (Clark et al.,1999). It is synthetised by chondrocites and synovial cells after activation 
of proinflammatory cytokines. This protein is an ingredient of collagen, type II, and it 
stimulates and regulates fibryllogenesis and stabilises collagen net in cartilage tissue. It is 
useful as a marker of early cartilage destruction, because it is first emmited in the process of 
collagen net splitting, which results in cartilage deterioration (Larson et al.,2004).  
Human cartilage glycoprotein (YKL-40) is a glycoprotein with molecular mass 38-40 kDa. It 
has a significant role in tissue remodelling, including the joint cartilage. YKL-40 is synthetised 
and secreted by hondrocites and synovial cells, also by activated macrophages, liver fibrocytes 
and colon, breast, lung, ovary and prostate cancer cells (Hakala et al.,1993,Register et al.,2001), 
as well as osteosarcoma cells (MG-63) (Johansen et al.,1993). It is not known what is the 
biological function of YKL-40 in malignant tumors, but it has been proven that this 
glycoprotein stimulates growth of connective tissue cells and chemotaxis. In persons with 
healthy cartilage, the level of YKL-40 in serum is low, while in the conditions of inflammation 
or extracellular matrix remodeling, there is a considerable increase in the level of this 
glycoprotein (Johansen et al.,2001,Volck et al.,1999). For these reasons YKL-40 can be used as a 
marker of cartilage and synovial tissue metabolism (Harvey et al.,1998). Collagen, type I, and 
non-collagen proteins are biomarkers of bone tissue metabolism. Researches of Rovetta et al 
(Rovwtta et al.,2003) showed much higher values of the collagen type I – CTX-I decomposition 
product in the serum of the patients with the errosive hand osteoarthrosis comparing to the 
patients with non-errosive hand osteoarthrosis. The study by Berger et al showed that the 
patients with the rapidly destructive osteoarthrosis have higher values of CTX-I in serum than 
the patients with slightly progressive osteoarthrosis (Berger et al.,2005).  
2.3.1 The knee osteoarthrosis inflammatory change diagnosis by biomarkers 
The joint inflammation in osteoarthrosis is usually mild and does not disturb the parameters 
of inflammation acute phase, but can be proved by the serum markers which indicate 
synovial activities (Garnero et al.,2001,2003,Kraus,2005). Metabolic changes of cartilage 
tissues in arthroses imply changes in matrix synthesis and degradation, and matrix 
molecules are excreted as fragments into the joint liquid, blood and urine, where they can be 
detected and measured (Lohmander,2004). 
In this research, the concentration of the biomarkers COMP, YKL-40 and CTX-I was 
measured in serum of the patients with knee osteoarthrosis. Comparing to effusion scope 
(minimal, moderate or serious), considerable difference in average values of COMP, YKL-40 
and CTX-I biomarker concentration (p=0,361, p=0,690 and p= 0,108, respectively) was not 
found, probably because of insufficient sensitivity of clinical examination in detection of 
synovial inflammation.  
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Significant difference of COMP biomarkers average values in serum was indicated, 
depending on presence of effusion during ultrasound examination, regardless its location 
and size. The patients with effusion in the knee have higher COMP concentrations in serum, 
comparing to the patients without effusion detected by ultrasound (Table5.). That implies 
that increased COMP concentration in serum can be a good indicator of synovial 
inflammation in the knee joint arhrosis (Živanović et al.,2009).  
 
EFFUSION 
Number of 
subjects 
N 
Percentage 
of subjects 
% 
COMP (ng/mL) 
Median 
25-th perc. 50-th perc. 75-th perc. 
present 22 25.0 44.50 54.00 58.00 
absent 66 75.0 48.75 57.00 64.25 
     p = 0.030 
 
SYNOVITIS 
Number of 
subjects 
N 
Percentage 
of subjects 
% 
COMP (ng/mL) 
Median 
25-th perc. 50-th perc. 75-th perc. 
present 29 33.0 45.5 52.0 58.0 
absent 59 67.0 50.0 58.0 66.0 
     p = 0.006 
Table 5. Comparison of the median of the concentration of COMP biomarker between 
patients with present or absent effusion and prolipheration of synovial membrane 
It was also found that there was a significant difference in serum COMP biomarker 
concentration average values between the patients with and without synovial membrane 
proliferation found by ultrasound, regardless the location and size. This evidence implies 
the fact that COMP biomarker values increase in serum when the knee joint inflammation is 
present as synovial membrane hypertrophy. However, COMP biomarker values can only 
confirm existence of synovial inflammation, i.e. detect it. Its increased concentrations cannot 
precisely determine inflammation degree (size) nor its location (in recess).  
A research related to synovitis type showed that there is a significant difference in COMP 
average concentrations in serum in patients with nodular, diffusive or nodular-deffusive 
synovitis. Highest COMP concentrations in serum were determined in patients with 
diffusive synovitis, which confirms the fact that diffusive proliferative synovitis causes the 
most intensive inflammation, if it occurs in the knee joint arthrosis (Figure 6.).  
The patients with knee artrosis accompanied with knee effusion and synovitis, have higher 
concentrations of COMP biomarkers in serum, than the patients without ultrasound 
indicators of synovial inflammation, which confirms that COMP can be a good indicator of 
synovial inflammation. 
During researches of sensitivity and specificity by ROC graph (Receiver Operating 
Characteristic) it was found that among analysed serum parameters only COMP parameter 
can be an indicator of effusion in the knee joint. COMP biomarker sensitivity on effusion 
was 59%, and its specificity 50% (cut off=53,5; area 0,665; p=0,030; confidence interval 0,534-
0,776). Cut off value was found to be 53,5 ng/ml, which means that no patients with 
osteoarthrosis and COMP biomarker concentrations in serum below 53,5 ng/ml have knee 
joint inflammation, while COMP biomarker values above 53,5 ng/ml indicate presence of 
inflammation. It means that the Cartilage matrix oligomeric protein have a moderate 
signifficance at effusion presence estimation (Figure 7.) (Živanović et al.,2011).  
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Fig. 6. Comparation of median of COMP biomarker concentration between patients with 
nodular, diffusive or nodular-difussive synovitis (p=0,014) 
 
 
Fig. 7. Cartilage Matrix Oligomeric Protein as a marker of the effusion cut off = 53.5 ng/mL; 
Area 0.655; p=0.030; confidence interval 0.534-0.776 
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It was not proved for any of the investigated markers that they could be indicators of the 
synovial membrane i.e. synovitis proliferation. Presented results of the research did not 
confirm significant correlation between mean values of YKL-40 and CTX-I biomarkers with 
inflammation (effusion and/or synovitis) in the knees with arthrosis.  
2.3.2 Diagnosis of destructive changes of the knee with osteoarthrosis by biomarkers 
The results of this  research indicated the negative correlation between YKL-40 values in 
serum and cartilage thickness on the medial femur condyle (front view). It showed that 
YKL-40 increased concentrations are associated with reduced thickness of the knee joint 
cartilage, especially medially, and vice versa (Table 6.). At the finding of a thinning cartilage, 
especially on the medial femur condyle, high values of YKL-40 in serum can be expected in 
patients with knee osteoarthrosis. As in the early phase of knee arthrosis the destructive 
changes on the joint cartilage dominantly occur on the medial tibia and femur condyle, it 
can be concluded on the bases of the provided results that increased concentrations of YKL-
40 in serum can be a good indicator of early damage of joint cartilage (Živanović et al.,2009).  
 
cartilage 
thickness 
(mm) 
concentration of biomarkers (ng/ml)
COMP YKL 40 CTX I 
r p r p r p 
medial.condil 
(front access) 
-0,177 0,099 -0,249 0,019 -0,043 0,691 
medial.condil 
(back access) 
-0,184 0,087 -0,056 0,608 -0,018 0,866 
lateral.condil 
(front access) -0,067 0,538 -0,080 0,460 -0,087 0,423 
Table 6. Correlation between serum concentration of biomarkers COMP, YKL 40 and CTX I 
with cartilage thickness (mm) in the medial (front and back access) and lateral (front access) 
femur condyles  
Correlation of other biomarkers' concentrations with the size of joint cartilage was not 
proved, so that it can be concluded on the basis of the provided results that their increased 
concentrations in the patients' serum cannot be a good parameter for the joint cartilage 
damage degree in patients with knee joint osteoarthrosis (Živanović et al.,2009).  
This research shows that there is a considerable difference in COMP and YKL-40 biomarkers 
concentration mean values between the patients with shorter and longer osteophytes on 
tibia and femur condyles (p=0,000) (Table 7.,8.). 
 
OSTEOPHYTES 
Number of 
subjects 
N 
Percentage 
of subjects 
% 
mid.value COMP (ng/ml) 
25th perc. Median 75th perc. 
Shorter 21 23,9 46,5 55,0 59,0 
Longer 67 76,1 48,0 56,0 64,0 
    p = 0,000 
Table 7. Comparison of the median of the concentration of biomarker COMP between 
patients with shorter and longer osteophytes.  
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OSTEOPHYTES 
Number of 
subjects 
N 
Percentage 
of subjects 
% 
mid.value YKL 40  (ng/ml) 
25th perc. Median 75th perc. 
Shorter 21 23,9 44,5 62,0 90,0 
Longer 67 76,1 80,0 119,0 171,0 
    p = 0,000 
Table 8. Comparison of the median of the concentration of biomarker YKL40 between 
patients with shorter and longer osteophytes.  
Osteophytes and bone erosions occur as consequence of damage and loss of cartilage tissue 
accompanied with cartilage destruction, and indirectly reflect the damage degree. Increased 
concentration of YKL-40 biomarker can be an indicator of destructive changes degree in the 
knee osteoarthrosis. That indicates a possibility of using this marker to estimate the joint 
destruction (Živanović et al.,2009). 
Conclusions of this research comply with the results by Johansen et al (Johansen et al.,1996) 
which showed that in the patients at later stage of knee osteoarthrosis there is an increased 
level of YKL-40 in serum. Contrary to that, Garnero's study (Garnero,2001) did not prove 
high concentrations of YKL-40 in patients with the late-stage osteoarthrosis (Figure 8.).  
 
 
Fig. 8. Link between the middle value (median) of biomarker YKL40 and duration of the 
knee OA (r = 0,651, p = 0,000) 
This research results showed that YKL-40 biomarker can be a highly sensitive marker of 
occurrence of longer osteophytes. Sensitivity of YKL-40 concentration in serum on 
occurrence of longer osteophytes on tibia and femur condyles is 79,1%, and its specificity 
61,9% (cut off 75,0; area 0,806; p=0,000; confidence interval 0,706-0,906). The cut off value 
75,0 ng/ml indicates that all the patients with osteoarthrosis and serum YKL-40 values 
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below 75,0 ng/ml have milder degree of joint destruction comparing to the patients with 
YKL-40 value above 75,0 ng/ml who have higher-degree joint destruction and the presence 
of longer osteophytes in the knee joint (Figure 9.) (Živanović et al.,2009). 
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cut off = 75,0; Area 0,806; p=0,000; confidence interval 0,706-0,906 
Fig. 9. YKL 40 as a marker for appearance of longer osteophytes at the tibia and femur 
condyles 
It was found that there is a considerable diference of YKL-40 mean values depending on the 
presence or absence of bone erosions on tibia and femur condyles (Table 9) (Živanović et 
al.,2010)  
 
 Bone erosion 25-th per median 75-th per 
COMP 
(ng/ml) 
absent 46 55 59,50 
present 48 57 63 
    p=0,483 
YKL-40 
(ng/ml) 
absent 46,50 81 120,50 
present 79 111 171 
    p = 0,004 
CTX-I 
(ng/ml) 
absent 0,71 0,93 1,10 
present 0,64 0,83 1,11 
 p =0,528 
Table 9. Comparation of median) concentrations of biomarkers between patients with 
present or absent bone erosions 
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Higher concentration of YKL-40 in serum can be found when there is a severe destruction of 
bones at the joint edges. The highest YKL-40 values were found in patients with erosions on 
the medial condyles (Figure 10.) (Živanović et al.,2010). 
COMP and CTX-I biomarkers are not good indicators (markers) of erosions on tibia and 
femur condyles, unlike YKL-40 which can be a good indicator of erosions (Figure 11.).  
YKL-40 sensitivity on occurrence of erosions on tibia and femur condyles is 69,5%, and its 
specificity is 51,7% (cut off=84,5; area 0,691; p=0,004; confidence interval 0,574-0,808). It 
was found that the cut off is 84,5ng/ml, which means that all the patients with 
osteoarthrosis YKL-40 value below 84,5ng/ml have milder degree of destruction without 
occurrence of bone erosions, and that YKL-40 values above 84,5ng/ml indicate higher 
degree of the joint destruction which implies bone erosion (Figure12.) (Živanović et 
al.,2010).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10. Differences in mean values (median) of biomarkers YKL-40 concentration in patients 
with present or absent erossions on the medial and/or lateral the tibia and femoral condyles  
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Fig. 11. Biomarkers COMP, YKL-40 and CTX-I as a markers to appear bone erossion in the 
condyles of the tibia and femur 
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Fig. 12. Biomarker YKL 40 as a marker to appear bone erossion in the condiles of tibia and 
femur 
www.intechopen.com
 Biomarkers and Ultrasound in the Knee Osteoarthrosis Diagnosis 
 
107 
The results of this research comply with the research results of Morgante et al (Morgante et 
al.,2001) who determined that YKL-40 is a good prognostic marker of joint destruction. On 
the other hand, Kawasaki's study showed different evidence related to hip osteoarthrosis. 
YKL-40 value in serum is a better indicator of synovial inflammantion degree than of the 
cartilage tissue metabolism (Kawasaki et al.,2001).  
 In this research the results of multivariant binary logistic regression show that the duration 
of disease is related to YKL-40 biomarker values in serum. Comparing the YKL-40 
concentration mean values with reference to 5, 10, 15 and 20 years duration of the disease, 
considerable differences were determined (p=0,000). YKL-40 biomarker mean value 
increases with disease duration (Figure 13.) (Živanović et al.,2009).  
 
 
Fig. 13. Increase in concentration of YKL40 for the duration of knee osteoarthrosis (after 5, 
10,15 i 20 years) 
In the patients with a long-lasting knee arthrosis and with progressed degenerative changes, 
osteophytes and bone erosions, higher concentrations of YKL-40 can be found in serum. 
That proves that YKL-40 biomarker can be a valid indicator of knee osteoarthrosis 
destructive changes (Živanović et al.,2009). 
2.3.3 Biomarkers as indicators of the pain degree and knee osteoarthrosis 
deterioration 
Analysis and comparation of the biomarkers concentration in serum between a group of 
patients with deterioration of knee osteoarthrosis and a group of patients without 
deterioration have been conducted.  
The patients with deterioration of knee osteoarthrosis have similar biomarker concentration 
values as the patients without symptoms and signs of the disease deterioration. Correlation 
between VAS mean values and concentration of investigated biomarkers was not proven 
either. That indicates that values of investigated biomarkers cannot be valid indicators of 
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pain intensity nor manifestation of disease deterioration in patients with knee 
osteoarthrosis. 
3. Conclusion 
This study has shown advantages of arthrosonography which distinguish it from the other 
methods of visualisation, especially at estimation of the knee osteoarthrosis deterioration. 
The disease deterioration, i.e. sudden intensification of pain the patients undergo is 
associated with the finding of synovial inflammation at the knee arthrosonography, as well 
as with presence of the Baker's cyst in the knee popliteal fossa.  
It is emphasised that arthrosonography is a more sensitive method than clinical examination 
at identification of location and size of effusion and synovial proliferation in the knee joint 
osteoarthrosis, as well as at detection and estimation of Baker's cyst size, especially in 
patients with intensive pain but without clinical singns of effusion or Baker's cyst existence.  
This study presents serum biomarkers as detectors of inflammatory and destructive changes 
in the knee joint with osteoarthrosis. It is recommended to measure Cartilage Oligomeric 
Matrix Protein – COMP concentration in serum for estimation of synovial inflammation, and 
Human Cartilage Glycoprotein 39 – YKL-40 at estimation of joint and bone cartilage 
damage.  
Application of biomarkers as a diagnostic method is much more expensive than 
arthrosonography, which means that it is not accessible to all the patients. It takes a couple 
of days to get results on concentration of biomarkers in serum, thus it cannot be said that it 
is a quick method. Some patients feel uneasy when giving blood sample for tests, which 
makes the method relatively aggressive and it is not possible to repeat it often. It should also 
be emphasised that measuring of biomarker concentration in serum does not provide 
precise data on size and location of inflammatory and destructive changes in the knee joint 
with osteoarthrosis, but only detects them.  
On the other hand, the advantages of arthrosonography that distinguish it from the other 
diagnostic methods are accessibility and low price, noninvasiveness, quick and precise 
presentation of both normal and patological soft-tissue structures, as well as possibility of 
frequent repetitions. The quality of ultrasound examination depends on technical 
equipment and of the doctor's experience. Anyway, standardisation of the equipment and 
expert knowledge usually produce a good-quality examination.  
This study recommends that arthrosonography should become routine and fundamental 
method in contemporary rheumatological practice, and a complement to clinical 
examinations.  
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